Navigation Links
Cambridge Semantics to Speak at 2013 Bio-IT World Conference & Expo
Date:4/2/2013

Boston, MA (PRWEB) April 02, 2013

Cambridge Semantics will again be a featured presenter at the annual Bio-IT World Conference & Expo. During this month’s event, Cambridge Semantics Vice President of Marketing and Technology, Lee Feigenbaum will speak on a new conference track, “Data Visualization and Exploration” which highlights novel visualization approaches that address important challenges in genomic data, networks, microscopy, imaging and the support of discovery, clinical and translational research. During his session, Mr. Feigenbaum will address Unified Information Access and its role in data exploration and visualization. To learn more visit http://www.bio-itworldexpo.com or visit the Cambridge Semantics booth #129 at the event.

Featured presentation:

  •     Date and time: Wednesday, April 10th at 12:00 p.m. EST
  •     Title: Whence the Data? The Importance of Feeding the Right Data to Your Visualizations
  •     Session description: Visualizations are only as good as the data that drives them.
Frequently, the right data comes from many and diverse sources. This discussion will present the case for Unified Information Access, a paradigm that lets you easily combine structured and unstructured data from inside and outside your organization in support of ever-evolving data exploration and visualization. Examples will include practical applications for competitive intelligence, safety, and assay data management.

In addition, Cambridge Semantics executives will be onsite at booth #129 demonstrating the company’s Competitive Intelligence and Drug Safety & Pharmacovigilance solutions. At the 2012 Bio-IT World Conference Cambridge Semantics’ Competitive Intelligence Solution was named “Best of Show” for its unique approach to helping pharma companies handle their diverse and ever-changing information needs. The company’s Drug Safety & Pharmacovigilance solution helps pharma reduce operational cost and improve risk management by automating and streamlining the process of discovering, managing, and analyzing adverse drug reactions.

About Cambridge Semantics
Cambridge Semantics provides the award-winning Anzo software suite, an open platform for building interactive Unified Information Access (UIA) solutions. Enterprises face an increasing need to rapidly discover, understand, combine, and act on data from diverse sources both from within and across organizational boundaries. Anzo makes it easy for both IT and end users to deal with this need by rapidly creating solutions that leverage unified access to structured and unstructured data from varied sources in the context of specific business problems.

Cambridge Semantics is privately held and based in Boston, Massachusetts. For more information visit http://www.cambridgesemantics.com or follow us on Twitter @CamSemantics.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10589552.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Cambridge Semantics Named 2013 SIIA CODiE Award Finalist
2. P&P Optica Invited to Cambridge Innovation Centre for the Canadian Technology Accelerator Program, One of Eight Canadian Life Science Companies Chosen to Participate
3. H3 Biomedicine Expands Cambridge Facilities, Doubles Employee Base as Scientific Program Advances
4. Cambridge Healthtech Associates™ Co-Sponsors BIO Debrief Networking Reception with Xconomy
5. Stevenage Bioscience Catalyst to Welcome Cambridge University Researchers
6. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
7. Susan Cain Will Kick Off 2013 ASAE Annual Meeting & Exposition, Dan Heath is Closing General Session Speaker
8. Clinverse CEO to Speak at MAGI East 2013
9. Lou Paradise, President and Chief of Research, Topical BioMedics, Inc. Slated to Speak at Integrative Healthcare Symposium
10. iLuv Introducing NFC & Qi-Certified Technology to Bluetooth Speaker Lineup at 2013 CES
11. VBI’s Dr. Szczepan Baran is an Invited Speaker at the Swiss Laboratory Animal (SGV) National Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... 28, 2016 Q BioMed ... Company,s CEO  was featured in an article he ... VCs Fear To Tread: http://www.lifescienceleader.com/doc/accelerators-enter-when-vcs-fear-to-tread-0001 ... is an essential business journal for life ... biotechs to Big Pharmas. Their content is designed ...
(Date:4/28/2016)... , ... April 28, 2016 , ... ... significant investments in recruiting top industry experts, and expanding its LATAM network and ... industry-leading tools for clients to manage their clinical trial projects. , The expansion ...
(Date:4/27/2016)... ... 2016 , ... Shimadzu Scientific Instruments (SSI) will be showcasing ... Conference and Expo. Shimadzu’s high-performance instruments enable laboratories to test cannabis products for ... stop by booth 1021 to learn how Shimadzu’s instruments can help improve QA/QC ...
(Date:4/27/2016)... , April 27, 2016 ... NSK) (OTCPink: NSKQB) ( Frankfurt : ... ihre Pressemitteilung vom 13. August 2015 die Genehmigung ... Finanzen um zusätzliche 200.000.000 Einheiten auf 400.000.000 Einheiten ... zu bringen. Davon wurden 157.900.000 Einheiten mit dem ...
Breaking Biology Technology:
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
(Date:4/14/2016)... AVIV, Israel , April 14, 2016 ... Behavioral Authentication and Malware Detection, today announced the appointment ... already assumed the new role. Goldwerger,s leadership ... BioCatch, on the heels of the deployment of its ... addition, BioCatch,s behavioral biometric technology, which discerns unique cognitive ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
Breaking Biology News(10 mins):